Frontlight ResearchEarly access
Macular degeneration trials in United States
23 of 95 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleCell Collection to Study Eye Diseases
- Where
- Bethesda
- Age
- 1 day to 120 years
- People
- 930
- Run by
- National Eye Institute (NEI)
See details and how to joinNCT01432847 - No phaseTaking peoplePivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration
- Where
- Richmond Hill
- Age
- 50 years and over
- People
- 1,076
- Run by
- iHealthScreen Inc
See details and how to joinNCT07084883 - No phaseTaking peopleAge-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
- Where
- Atlanta, Dallas, Erie, Fargo, Madison, McAllen, Salt Lake City, The Woodlands
- Age
- 50 years and over
- People
- 1,000 worldwide
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT06924021 - No phaseTaking peopleNational Eye Institute Biorepository for Retinal Diseases
- Where
- Bethesda
- Age
- 2 years to 120 years
- People
- 650
- Run by
- National Eye Institute (NEI)
See details and how to joinNCT01496625 - No phaseTaking peopleA Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
- Where
- Bethlehem, Carmel, Dallas, Durham, La Crosse, Mountain View, Oak Forest, Reno, Springfield, Wake Forest
- Age
- 55 years and over
- People
- 75 worldwide
- Run by
- Complement Therapeutics
See details and how to joinNCT07144137 - No phaseTaking peoplePrescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
- Where
- Ann Arbor, Baltimore, Boston, Cincinnati, Dallas, Gainesville, Houston, San Francisco
- Age
- 5 years and over
- People
- 50
- Run by
- Ascidian Therapeutics, Inc
See details and how to joinNCT06445322 - No phaseTaking peopleA Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (GLOBALIGHT)
- Where
- Beverly Hills, Charleston, Cincinnati, McAllen, Silverdale
- People
- 500 worldwide
- Run by
- LumiThera, Inc.
See details and how to joinNCT06351605 - No phaseTaking peopleNoninvasive Imaging Biomarkers of Treatable Macrovascular Disease in Age-related Macular Degeneration.
- Where
- Cleveland
- Age
- 50 years to 80 years
- People
- 30
- Run by
- Scott Raymond
See details and how to joinNCT07798323 - No phaseNot yet taking people in United StatesA Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
- Where
- Boston, Katy, Norfolk
- Age
- 50 years and over
- People
- 83 worldwide
- Run by
- Skyline Therapeutics
See details and how to joinNCT06346600 - No phaseEnrolling by invitationLong-Term Follow Up of VOY-101 Non-nAMD Extension Study
- Where
- Bellaire, Boston, Salt Lake City
- Age
- 50 years and over
- People
- 88 worldwide
- Run by
- Perceive Biotherapeutics, Inc.
See details and how to joinNCT07660640 - No phaseTaking peopleLesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).
- Where
- Salt Lake City
- Age
- 65 years to 90 years
- People
- 50
- Run by
- University of Utah
See details and how to joinNCT07582042 - No phaseTaking peopleInherited Retinal Degenerative Disease Registry
- Where
- Columbia
- People
- 20,000
- Run by
- Foundation Fighting Blindness
See details and how to joinNCT02435940 - No phaseTaking peopleAdaptive Optics Imaging of Outer Retinal Diseases
- Where
- Bethesda, Silver Spring
- Age
- 21 years and over
- People
- 100
- Run by
- Food and Drug Administration (FDA)
See details and how to joinNCT05355415 - No phaseTaking peopleHigh Resolution Retinal Imaging
- Where
- Philadelphia
- Age
- 7 years and over
- People
- 600
- Run by
- University of Pennsylvania
See details and how to joinNCT01866371 - No phaseTaking peopleCentral micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study
- Where
- San Francisco
- Age
- 55 years and over
- People
- 80
- Run by
- University of California, San Francisco
See details and how to joinNCT07556406 - No phaseTaking peopleDevelopment and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)
- Where
- Irvine
- Age
- 18 years and over
- People
- 25
- Run by
- Ray Therapeutics, Inc.
See details and how to joinNCT07502664 - No phaseTaking peopleProgression of Early Atrophic Lesions
- Where
- Salt Lake City
- Age
- 50 years and over
- People
- 125
- Run by
- University of Utah
See details and how to joinNCT05959005 - No phaseTaking peopleReal-World Evaluation of AI Enabled Multi-Spectral Imaging (MSI) for AMD Biomarker Detection
- Where
- Woodbridge
- Age
- 40 years and over
- People
- 1,000
- Run by
- AI-Spectral
See details and how to joinNCT07446582 - No phaseTaking peopleA Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
- Where
- Dallas
- Age
- 18 years and over
- People
- 30
- Run by
- Nanoscope Therapeutics Inc.
See details and how to joinNCT06805474 - No phaseTaking peopleNYSCF Scientific Discovery Biobank
- Where
- New York
- Age
- 30 days and over
- People
- 10,000
- Run by
- New York Stem Cell Foundation Research Institute
See details and how to joinNCT06203106 - No phaseTaking peopleObservational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
- Where
- Irvine
- Age
- 18 years and over
- People
- 120
- Run by
- Ray Therapeutics, Inc.
See details and how to joinNCT06375239 - No phaseTaking peopleNovel Glaucoma Diagnostics
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 5,000
- Run by
- Wills Eye
See details and how to joinNCT00286637 - No phaseTaking peopleOCT Angiography in Wet AMD
- Where
- Portland
- Age
- 50 years to 100 years
- People
- 160
- Run by
- Oregon Health and Science University
See details and how to joinNCT02253030